MARKET WIRE NEWS

Greenhaven Road Capital Main Fund Q1 2025 Investor Letter

Source: SeekingAlpha

2025-05-19 09:20:00 ET

Summary

  • Despite a tough Q1 and tariff-driven volatility, our core holdings remain fundamentally strong and positioned for long-term growth.
  • We increased positions in Lifecore, Vistry Group, and Hagerty, capitalizing on market overreactions and their resilience to trade policy shifts.
  • Kingsway Financial is a compelling, overlooked opportunity, scaling the proven search fund model with top-tier advisors and strong acquisition discipline.
  • Most portfolio companies are minimally impacted by tariffs; I remain confident in our fundamentals and see significant upside as market focus returns.

Dear Fellow Investors,

The Fund 1 returned approximately ?12% net of fees and expenses in the first quarter 2 . Please refer to your individual statements for exact performance as returns will vary by fund, class, and timing of investment....

Read the full article on Seeking Alpha

For further details see:

Greenhaven Road Capital Main Fund Q1 2025 Investor Letter
Lifecore Biomedical Inc.

NASDAQ: LFCR

LFCR Trading

-0.29% G/L:

$6.90 Last:

3,498 Volume:

$6.72 Open:

mwn-app Ad 300

LFCR Latest News

LFCR Stock Data

$276,501,678
20,569,027
4.87%
36
N/A
Biotechnology & Life Sciences
Healthcare
US
Chaska

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App